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CorrespondencePericardial effusion due to Cryptococcus neo-452formans in a patient with cystic fibrosis follow-
ing lung transplantation
Cryptococcus neoformans is an encapsulated basidiomyce-
tous yeast with a worldwide distribution that is an opportu-
nistic fungal pathogen in immunocompromised patients.1,2
However C. neoformans has not been reported, to date, as
the agent of pericarditis in a patient with cystic fibrosis (CF)
after lung transplantation.
A 20-year-old female who had undergone lung trans-
plantation for CF 8 months before, was admitted to the
hospital in July 2005 because of sudden and severe dyspnea
at rest and chest pain, accompanied by a 1-week fever
(39 8C), asthenia, and abdominal pain. A chest radiogram
showed cardiac enlargement. A transthoracic echocardio-
graphy revealed a large anterior and posterior pericardial
effusion. Her serum C-reactive protein level was at
179 mg/l. A pericardial drainage including a pericardium
biopsy was cultured yielding C. neoformans after 6 days of
incubation on Columbia blood agar plates. Real-time quan-
titative PCR targeting the region between 18S and 28S RNA
gene, performed either on the pericardial fluid or on the
colonies isolated on agar, were positive for C. neoformans.
Standard blood cultures were negative. A treatment with
fluconazole 400 mg/day was initiated. Fever resolved com-
pletely within 2 weeks and the volume of pericardial fluid
decreased significantly. She was discharged from hospital 6
days after the pericardial drainage, in healthy condition.
Immune status and follow-up were not available for the
patient.
Fungal pericarditis has been reported only rarely as the
potential cause of tamponade in the HIV population3 and in
intravenous drug abuse.4 In CF transplanted patients, one
case of purulent pericarditis due to Pseudomonas aeruginosa
prior to lung transplantation,5 one case due to Burkholderia
cepacia after the lung allograft,6 and one case ofMycoplasma
pneumoniae7 have been reported. We report herein a case of
pericardial effusion due to C. neoformans in a patient with
bipulmonary transplantation for CF. Fungal pericarditis asso-
ciated with transplantation is rarely reported in the litera-
ture8 and often undiagnosed. Cases of Candida purulent
constrictive pericarditis in immunocompromised patients
have been reported9 as well as fatal cases of Aspergillus
pericarditis in immunocompromised patients.10
Because the mortality rate is high, systematic evaluation
of pericardial fluid using microbiological cultures, molecular
techniques, and histopathological examination remains com-
plementary to a systematic strategy involving non-invasive
procedures.
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